Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly.
Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, Ferrari C, Guerra UP, Paghera B, Muscio C, Bianchetti A, Volta GD, Turla M, Cotelli MS, Gennuso M, Prelle A, Zanetti O, Lussignoli G, Mirabile D, Bellandi D, Gentile S, Belotti G, Villani D, Harach T, Bolmont T, Padovani A, Boccardi M, Frisoni GB; INDIA-FBP Group. Cattaneo A, et al. Among authors: festari c. Neurobiol Aging. 2017 Jan;49:60-68. doi: 10.1016/j.neurobiolaging.2016.08.019. Epub 2016 Aug 31. Neurobiol Aging. 2017. PMID: 27776263 Free article.
Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study.
Boccardi M, Altomare D, Ferrari C, Festari C, Guerra UP, Paghera B, Pizzocaro C, Lussignoli G, Geroldi C, Zanetti O, Cotelli MS, Turla M, Borroni B, Rozzini L, Mirabile D, Defanti C, Gennuso M, Prelle A, Gentile S, Morandi A, Vollaro S, Volta GD, Bianchetti A, Conti MZ, Cappuccio M, Carbone P, Bellandi D, Abruzzi L, Bettoni L, Villani D, Raimondi MC, Lanari A, Ciccone A, Facchi E, Di Fazio I, Rozzini R, Boffelli S, Manzoni L, Salvi GP, Cavaliere S, Belotti G, Avanzi S, Pasqualetti P, Muscio C, Padovani A, Frisoni GB; Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Working Group. Boccardi M, et al. Among authors: festari c. JAMA Neurol. 2016 Dec 1;73(12):1417-1424. doi: 10.1001/jamaneurol.2016.3751. JAMA Neurol. 2016. PMID: 27802513
Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET.
Altomare D, Ferrari C, Festari C, Guerra UP, Muscio C, Padovani A, Frisoni GB, Boccardi M; Incremental Diagnostic Value of Amyloid PET With [(18)F]-Florbetapir (INDIA-FBP) Working Group. Altomare D, et al. Among authors: festari c. Alzheimers Dement. 2018 Aug;14(8):1088-1098. doi: 10.1016/j.jalz.2018.02.022. Epub 2018 Apr 19. Alzheimers Dement. 2018. PMID: 29679576
Clinical utility of FDG-PET for the clinical diagnosis in MCI.
Arbizu J, Festari C, Altomare D, Walker Z, Bouwman F, Rivolta J, Orini S, Barthel H, Agosta F, Drzezga A, Nestor P, Boccardi M, Frisoni GB, Nobili F; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders. Arbizu J, et al. Among authors: festari c. Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1497-1508. doi: 10.1007/s00259-018-4039-7. Epub 2018 Apr 27. Eur J Nucl Med Mol Imaging. 2018. PMID: 29704037 Review.
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia.
Boccardi M, Festari C, Altomare D, Gandolfo F, Orini S, Nobili F, Frisoni GB; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders. Boccardi M, et al. Among authors: festari c. Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1470-1486. doi: 10.1007/s00259-018-4024-1. Epub 2018 Apr 30. Eur J Nucl Med Mol Imaging. 2018. PMID: 29713763 Review.
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.
Nestor PJ, Altomare D, Festari C, Drzezga A, Rivolta J, Walker Z, Bouwman F, Orini S, Law I, Agosta F, Arbizu J, Boccardi M, Nobili F, Frisoni GB; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders. Nestor PJ, et al. Among authors: festari c. Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1509-1525. doi: 10.1007/s00259-018-4035-y. Epub 2018 May 7. Eur J Nucl Med Mol Imaging. 2018. PMID: 29736698 Review.
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease.
Drzezga A, Altomare D, Festari C, Arbizu J, Orini S, Herholz K, Nestor P, Agosta F, Bouwman F, Nobili F, Walker Z, Frisoni GB, Boccardi M; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders. Drzezga A, et al. Among authors: festari c. Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1487-1496. doi: 10.1007/s00259-018-4032-1. Epub 2018 May 13. Eur J Nucl Med Mol Imaging. 2018. PMID: 29756163 Review.
Comparison of visual criteria for amyloid-PET reading: could criteria merging reduce inter-rater variability?
Paghera B, Altomare D, Peli A, Morbelli S, Buschiazzo A, Bauckneht M, Giubbini R, Rodella C, Camoni L, Boccardi M, Festari C, Muscio C, Padovani A, Frisoni GB, Guerra UP. Paghera B, et al. Among authors: festari c. Q J Nucl Med Mol Imaging. 2020 Dec;64(4):414-421. doi: 10.23736/S1824-4785.19.03124-8. Epub 2019 May 8. Q J Nucl Med Mol Imaging. 2020. PMID: 31089074
Medial temporal lobe atrophy and posterior atrophy scales normative values.
Cotta Ramusino M, Altomare D, Bacchin R, Ingala S, Bnà C, Bonetti M, Costa A, Barkhof F, Nicolosi V, Festari C, Frisoni GB, Boccardi M. Cotta Ramusino M, et al. Among authors: festari c. Neuroimage Clin. 2019;24:101936. doi: 10.1016/j.nicl.2019.101936. Epub 2019 Jul 15. Neuroimage Clin. 2019. PMID: 31382240 Free PMC article.
34 results